portrait 

portrait
» EUTox » Theses                  
           
   

Theses

 

The following PhD Students sucessfully completed their thesis within the EUTox Work group:

2004

B. Näsström: Lipoprotein lipase in hemodialysis patients and healthy controls: effects of heparin.

2005

V. Jankowski: Isolation, identification and characterization of vasoactive substances from endothelial cells, platelets and mononuclear cells.

2006

P. Jonsson: Safety and biological aspects of present techniques of haemodialysis.

2009

E. Schepers: In vitro research for the pathophysiological mechanisms of uremic retention solutes on leukocytes in relation to chronic inflammation and accelerated atheromatosis in chronic kidney diseases.

2010

T. Guenthner:"Angioprotectin": a vasoprotective angiotensin peptide".

M. Koehler: Contribution of known uremic retention solutes to the development of cardiovascular diseases in patients with chronic kidney disease.

E. Houthuys: Transcriptome analysis of monocytes and macrophages in mycobactrial infection and chronic kidney disease.

M. Luman: Dialysis Dose and Nutrition Assessment by an Optical Method.

2011

N. Meert: Optimisation of removal of uremic retention solutes by haemodialysis strategies.

2012

S. Salem: Isolation and identification of vasomodulating biomolecules

A. Pletinck: The peritoneal membrane as a window for microvascular pathophysiology in chronic kidney disease.

2013

F. Duranton: Natural history of chronic kidney disease. Analysis of pathophysiological and prognostic factors of renal failure and its complications.

J. Holmar: Optical Method for Uric Acid Removal Assessment During Dialysis.

B. Holmberg: Analysis of risk factors in patients with severe chronic kidney disease. The role of atovastatin.

D. Mahmood: Lipoprotein lipase activity is reduced in dialysis patients. Studies on possible causal factors.

U. Forsberg: Presence of microemboli during haemodialysis and methods to reduce the exposure to microbubbles.

2014

F. Böhringer: Development of clinical methods for increased removal of protein-bound uremic toxins in the context of an extracorporeal therapy.

J. Boelaert: Development of metabolic analytical platforms for the characterization of uremic retention compounds.

2015

N. Neirynck: Micro-inflammation and cardiovascular disease in chronic kidney disease: role of uremic peptides,

J. Siwy: Validation of an urinary classifier for diagnosis of diabetic nephropathy.

2016

M. Rueth: Hydrophobe Metabolite: Proteinaffinität, Quantifizierung und Methodische Ansätze zur Untersuchung vaskulärer Effekte. Major Chromophores and Fluorophores in the Spent Dialysate as Cornerstones for Optical Monitoring of Kidney Replacement Therapy.

J. Arund: Major Chromophores and Fluorophores in the Spent Dialysate as Cornerstones for Optical Monitoring of Kidney Replacement Therapy.

A. Bhat: Bioinformatics Modeling of Proteomics changes in Muscle Invasive Bladder Cancer.

A. Latosinska: Optimizing methodologies for clinical proteomics.

M. Pejchinovski: The role of urinary peptide markers in diagnosis and prognosis of servere renal diseases.

S. Filip: Identification of protein biomarkers for chronic kidney disease progression using state-of-the-art proteomics approaches.

O. A. Deif: Documentation and evaluation of uremic retention solutes through an interactive database

2017

C. Pontillo: Clinical peptidomics of non-invasive diagnosis and prognosis of renal diseases.

 

 

 

 
Upcoming Events
 
   
 
     
  Members    
     
     
     
     
     
 

 

 

 

 

 

 

 

 

 

 

 

 

 

   
   
   
   
   
   
     
     
     
     
     
     
     
     
     
     
     
     
     
     


Webmaster: V.Jankowski
Imprint

last change:
09.04.2017 1:11 PM

- Scientists from Academia
- Previous EUTox Meetings
- Scientists from Industry
- Members emeritus